《大行報告》瑞銀下調滔搏(06110.HK)目標價至14.17元 評級「買入」
瑞銀發表報告指,滔搏(06110.HK)2022財年上半年純利按年增長9%至14億元人民幣,符合該行預期。不過收入則按年下跌1%至156億元人民幣,遜於該行預期的162億元人民幣,主要由於疫情相關的客流損失,但被毛利率按年改善2.9個百分點至44.5%等抵銷。
瑞銀下調滔搏(06110.HK)股份目標價,以現金流折現率計,由15.63元降至14.17元,評級維持「買入」,並調低集團2022至2024財年盈利預測7%至11%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.